PT 141 is a peptide that is making a huge impact for men and women suffering from sexual dysfunction conditions. Unlike other aids to this condition like Viagra, Cialis, etc that effects the cardiovascular system helping blood flow, this what is heading to become a blockbuster for ED which affects most people in their life time works by stimulating the brain itself by stimulating libido, sexual desire and response quickly and for a long duration.

To make this peptide even more attractive is that it can be used in a nasal spray form as well as the traditional injection. Its ability to work for men and women is unique as well as not being affected by food or alcohol.

So PT 141 is set to take its place in the market place and trigger the beginning of a sexual revolution.  

PT 141 has been shown to have substantial effects on libido, generating sexual arousal in both men and women within minutes of administration.

‍

Benefits of PT 141

Results: More women reported moderate or high sexual desire following bremelanotide treatment vs. placebo.

Among women who attempted sexual intercourse within 24 hours after treatment, significantly more were satisfied with their level of sexual arousal following bremelanotide, compared with placebo.

Effects may be felt up to 12 hours from the time of administration and have been known to last for up to 3 days, diminishing each day.

PT- 141 has been shown to have significant results on male test patients, with what is described as “intense” and “frequent” erections lasting between 2-6 hours.

For women, sexual arousal has been experienced in a varied range of minutes to weeks.

Bremelanotide PT 141 was developed from the peptide hormone Melanotan II.

Effective in treating sexual dysfunction in men - impotence / erectile dysfunction and premature ejaculation.

Effective in treating sexual dysfunction in women – sexual arousal disorder.

Does not act upon the vascular system.

Increases sexual desire via the centralnervous system.

‍

Bremelanotide PT 141 was developed from Melanotan II, targeting its aphrodisiac effects. This peptide has been shown to have a substantial effect on libido, generating sexual arousal in both men and women within minutes of administration. It has been shown to be effective in treating erectile dysfunction, even in men who have not responded to other ED treatments, such as Viagra and Cialis and female sexual arousal and orgasmic disorders.

This peptide is also able to cross the blood-brain-barrier, bypassing the vascular system and acting at the level of the central nervous system. This property gives Pt 141 an advantage over traditional ED drugs, which can decrease blood pressure to dangerous levels.

During the studying of and experimentation with the tanning peptide, Melanotan II for melanoma prevention, sexual arousal and spontaneous erections were identified as a side effect in some of the test subjects. Testing was then carried out on human male volunteer subjects with a history of erectile dysfunction and nine of the original ten subjects experienced spontaneous erections when the drug was administered. Further studies revealed that the source of these effects was what is now referred to as PT-141. It works by activating specific melanocortin receptors. Through these chemical interactions.

PT-141 can influence multiple physiological responses such as appetite and sexual behaviour. Bremelanotide has shown potential in treating sexual dysfunction mainly male erectile dysfunction. Studies also reveal that PT-141 does not have any effect on the vascular system; instead, it allegedly works directly on the melanocortin receptors in the brain hence increasing sexual stimulation in test subjects.